生物活性

• 描述RD 162 is an orally active and very potent antagonist of androgen receptor (AR) and is a second-generation of antiandrogen for the treatment of advanced prostate cancer and highly recommended tool in AR research.
• 临床研究

• NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
  NCT02034500	Shigellosis	Phase 1	Completed	-	United Kingdom ... more >> Surrey Clinical Research Center (Surrey CRC) Guildford, Surrey, United Kingdom, GU2 7XP Collapse <<
  NCT02001987	Rheumatoid Arthritis	Phase 3	Completed	-	France ... more >> Amiens, France, 80054 Bordeaux, France, 33076 Brest, France, 29609 Caen, France, 14033 Cahors, France, 46005 Clermont-ferrand, France, 63003 Echirolles, France, 38434 La Source, France, 45100 Le Mans, France, 72037 Lille, France, 59037 Limoges, France, 87042 Lomme, France, 59462 Lyon cedex 3, France, 69437 Marseille, France, 13274 Marseille, France, 13285 Metz Tessy, France, 74370 Monaco, France, 98012 Montpellier, France, 34295 Mulhouse, France, 68070 Paris, France, 75475 Paris, France, 75571 Paris, France, 75651 Paris, France, 75679 Paris, France, 75877 Rennes, France, 35033 Rouen, France, 76031 St Mande, France, 94163 St Priest En Jarez, France, 42277 Strasbourg, France, 67098 Thonon Les Bains, France, 74203 Toulouse, France, 31059 Vandoeuvre-les-nancy, France, 54511 Collapse <<
  NCT03087565	Sexual Function Disturbances ... more >> Urinary Function Disorders Collapse <<	Not Applicable	Recruiting	December 2017	Egypt ... more >> Kasr Alainy medical school Recruiting Cairo, Egypt, 12151 Contact: Ahmed Maged, MD    01005227404    prof.ahmedmaged@gmail.com Collapse <<

• 更多